Kura Oncology, Inc. (NASDAQ:KURA) Receives Consensus Recommendation of Moderate Buy from Brokerages

Kura Oncology, Inc. (NASDAQ:KURA – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the eight ratings firms that are covering the company, MarketBeat.com reports. One analyst has rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 1-year price target among brokers […]

Related Keywords

Dekabank Deutsche Girozentrale ,Kura Oncology Inc ,Charles Schwab Investment Management Inc ,Jupiter Asset Management Ltd ,Nasdaq ,Walleye Capital ,York Mellon Corp ,Kura Oncology ,Get Free Report ,Oncology Trading Down ,Bank Deutsche Girozentrale ,New York Mellon Corp ,Schwab Investment Management ,Asset Management ,Get Free ,Kura Oncology Daily ,Nasdaq Kura ,Kura ,Medical ,Ratings ,Consensus ,